Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology

Kristian Kofoed; Uffe Vest Schneider; Troels Scheel; Ove Andersen; Jesper Eugen-Olsen

doi:10.1373/clinchem.2006.067595

Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology

Kristian Kofoed, Uffe Vest Schneider, Troels Scheel, Ove Andersen, Jesper Eugen-Olsen

BSc + MSc programme

Research output: Contribution to journal › Journal article › Research › peer-review

117 Citations (Scopus)

Abstract

Sepsis is a common and often fatal disease. Because sepsis can be caused by many different organisms, biomarkers that can aid in diagnosing sepsis and monitoring treatment efficacy are highly warranted. New sepsis markers may provide additional information to complement the currently used markers.

Original language	English
Journal	Clinical Chemistry
Volume	52
Issue number	7
Pages (from-to)	1284-93
Number of pages	10
ISSN	0009-9147
DOIs	https://doi.org/10.1373/clinchem.2006.067595
Publication status	Published - 2006

Access to Document

10.1373/clinchem.2006.067595

Cite this

@article{3d4ad2bb03084576894d5811177397cd,

title = "Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology",

abstract = "Sepsis is a common and often fatal disease. Because sepsis can be caused by many different organisms, biomarkers that can aid in diagnosing sepsis and monitoring treatment efficacy are highly warranted. New sepsis markers may provide additional information to complement the currently used markers.",

author = "Kristian Kofoed and Schneider, {Uffe Vest} and Troels Scheel and Ove Andersen and Jesper Eugen-Olsen",

year = "2006",

doi = "10.1373/clinchem.2006.067595",

language = "English",

volume = "52",

pages = "1284--93",

journal = "Clinical Chemistry",

issn = "0009-9147",

publisher = "American Association for Clinical Chemistry, Inc.",

number = "7",

}

TY - JOUR

T1 - Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology

AU - Kofoed, Kristian

AU - Schneider, Uffe Vest

AU - Scheel, Troels

AU - Andersen, Ove

AU - Eugen-Olsen, Jesper

PY - 2006

Y1 - 2006

N2 - Sepsis is a common and often fatal disease. Because sepsis can be caused by many different organisms, biomarkers that can aid in diagnosing sepsis and monitoring treatment efficacy are highly warranted. New sepsis markers may provide additional information to complement the currently used markers.

AB - Sepsis is a common and often fatal disease. Because sepsis can be caused by many different organisms, biomarkers that can aid in diagnosing sepsis and monitoring treatment efficacy are highly warranted. New sepsis markers may provide additional information to complement the currently used markers.

U2 - 10.1373/clinchem.2006.067595

DO - 10.1373/clinchem.2006.067595

M3 - Journal article

SN - 0009-9147

VL - 52

SP - 1284

EP - 1293

JO - Clinical Chemistry

JF - Clinical Chemistry

IS - 7

ER -